Glaucoma News and Research RSS Feed - Glaucoma News and Research

While there are many causes of glaucoma, most cases are associated with increased intraocular pressure. Loss of vision is usually characterized by a gradual reduction in peripheral vision, which can lead to a tunnel vision effect. Glaucoma affects approximately 100 million people globally and is one of the leading causes of blindness in the world today. An estimated three million Americans have this sight-threatening disease. Because it is painless and advances gradually, many people who have glaucoma or elevated IOP have not been diagnosed. If detected and treated early, vision can usually be preserved.
Comprehensive dilated eye exams may provide clear view of eye health

Comprehensive dilated eye exams may provide clear view of eye health

David Watson has worn glasses to correct nearsightedness the majority of his life, and had his vision checked regularly to make sure his prescription was up to date. But when his wife convinced him to have a comprehensive dilated eye exam, he got a surprise. His doctor told him something didn't look right with his retina, the light sensitive tissue at the back of his eye. His retina was torn, and he had not had any symptoms. [More]
Diabetic patients at risk for developing retinal diabetic neuropathy

Diabetic patients at risk for developing retinal diabetic neuropathy

A University of Iowa-led study of diabetes-related vision impairment holds good news -- and some bad news -- for patients with signs of these disorders. [More]

New methods for IOP measurements in patients with abnormal corneas

As a fundamental component of the ocular examination, accurate measurement of intra-ocular pressure (IOP) facilitates the management of patients with established glaucoma and the identification of patients with an elevated risk of developing glaucoma. For over 70 years, the most common method of measuring IOP has been by Goldmann Applanation Tonometry (GAT), largely on account of its low cost and ease of use. [More]
TKCI outlines plan to curb corneal blindness worldwide by 2030

TKCI outlines plan to curb corneal blindness worldwide by 2030

The Tej Kohli Cornea Institute in partnership with the world-renowned LV Prasad Eye Institute, has today laid out its plan to control corneal blindness, globally, by 2030. [More]
Research suggests new pathway for preventing optic nerve damage in KPro recipients

Research suggests new pathway for preventing optic nerve damage in KPro recipients

Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro) — similar to what glaucoma patients experience, without the rise of pressure in the eye — and have shown that blocking one of those factors, tumor necrosis factor alpha (TNFa), successfully halts the development of optic nerve damage in a mouse model. [More]
Researchers discover new genetic markers linked to increased risk of glaucoma

Researchers discover new genetic markers linked to increased risk of glaucoma

The investigation studied the genetic make up of about 40,000 people and identified five previously unknown genetic areas linked to an increased risk of primary angle closure glaucoma. [More]
Liu Laboratory at Augusta University studies exosomes using Particle Metrix’s ZetaView

Liu Laboratory at Augusta University studies exosomes using Particle Metrix’s ZetaView

Particle Metrix, developers of versatile particle characterization solutions for the life sciences, report on the work in the Liu Laboratory at Augusta University which is studying exosomes where size and concentration are critical parameters. [More]
New technologies go far beyond traditional use of contact lenses for vision correction

New technologies go far beyond traditional use of contact lenses for vision correction

Imagine contact lenses that can deliver medicines directly to the eye, slow progression of nearsightedness in children, or monitor glucose levels in patients with diabetes. [More]
IUPUI investigators use stem cells to identify potential therapies to prevent glaucoma

IUPUI investigators use stem cells to identify potential therapies to prevent glaucoma

Using stem cells derived from human skin cells, researchers led by Jason Meyer, assistant professor of biology, along with graduate student Sarah Ohlemacher of the School of Science at Indiana University-Purdue University Indianapolis, have successfully demonstrated the ability to turn stem cells into retinal ganglion cells (RGCs), the neurons that conduct visual information from the eye to the brain. [More]
Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

Researchers report outcomes of dipyridamole drug in treating pterygium and related dry-eye symptoms

At the Israeli Society for Vision and Eye Research conference on March 10, the MedInsight Research Institute and Center for Drug Repurposing at Ariel University presented the latest findings on positive user-reported outcomes of the repurposed drug dipyridamole in treating pterygium and related dry-eye symptoms. [More]
Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe. [More]
FDA allows marketing of one-time use contact lens to help measure patient's intraocular pressure

FDA allows marketing of one-time use contact lens to help measure patient's intraocular pressure

The U.S. Food and Drug Administration today allowed marketing of a one-time use contact lens that may help practitioners identify the best time of day to measure a patient's intraocular pressure (IOP). Elevated IOP is often associated with the optic nerve damage that is characteristic of glaucoma. [More]
IRIDEX reports revenues of $12.1 million for fourth quarter 2015

IRIDEX reports revenues of $12.1 million for fourth quarter 2015

IRIDEX Corporation today reported financial results for the fourth quarter and year ended January 2, 2016. [More]
Black, white Americans cope with pain differently

Black, white Americans cope with pain differently

Researchers led by Adam T. Hirsh of the School of Science at Indiana University-Purdue University Indianapolis report that black and white Americans cope with pain differently and that blacks employ pain coping strategies more frequently than whites. The IUPUI review and analysis of 19 studies is the first to examine the entire published literature and quantify the relationship between race and the use of pain-coping strategies. [More]
Study reveals another clue to workings of trachoma

Study reveals another clue to workings of trachoma

Another clue to the workings of trachoma - the world's leading infectious cause of blindness - has been revealed in a new study published in BMC Infectious Diseases. Researchers identified markers of genetic regulation present in the early stages of infection that could predispose children to developing the condition in its long-term, severe form. [More]
IRIDEX's Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma

IRIDEX's Cyclo G6 laser system receives CE Mark approval for treatment of glaucoma

IRIDEX Corporation, a leading global provider of innovative laser systems, delivery devices and consumables in ophthalmology, today announced that it has received its CE Mark to commercialize across Europe its first laser system in its class designed solely for use in treating glaucoma and its symptoms. [More]
Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire announces resubmission of lifitegrast NDA to FDA for treatment of dry eye disease in adults

Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015. [More]
Incidence of childhood myopia has more than doubled over last 50 years among American children

Incidence of childhood myopia has more than doubled over last 50 years among American children

The largest study of childhood eye diseases ever undertaken in the U.S. confirms that the incidence of childhood myopia among American children has more than doubled over the last 50 years. The findings echo a troubling trend among adults and children in Asia, where 90 percent or more of the population have been diagnosed with myopia, up from 10 to 20 percent 60 years ago. [More]
Age-related macular degeneration: an interview with Cathy Yelf, Macular Society

Age-related macular degeneration: an interview with Cathy Yelf, Macular Society

Age-related macular degeneration is a condition of the macula, a tiny area of the retina at the back of the eye. Your macula is only about the size of the grain of rice, that’s about four millimeters across. [More]
Three new genetic associations identified for primary open angle glaucoma

Three new genetic associations identified for primary open angle glaucoma

Researchers from Massachusetts Eye and Ear/Harvard Medical School and Case Western Reserve University School of Medicine have led an international effort to identify three genetic associations that influence susceptibility to primary open angle glaucoma -- the most common form of adult onset glaucoma and the leading cause of irreversible blindness in the world. [More]
Advertisement
Advertisement